drugset / Trial / NCT00356850

Ocular Pharmacokinetics After a Single Drop Instillation of T1225 0.5, 1, 1.5% in 91 Healthy Volunteers

NCT00356850

Phase 1 Completed Laboratoires Thea
RandomizedParallel-groupDouble-blindTreatment

Summary

To evaluate azithromycin tear concentrations after instillation of one drop of one of the three T1225 concentrations (0.5%, 1% and 1.5%) and to evaluate the ocular safety.

Timeline

Start
2002-05
Primary completion
Completion
2002-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Azithromycin Small molecule 0.5 % Other
Subject Azithromycin Small molecule 1 % Other
Subject Azithromycin Small molecule 1.5 % Other